H.R. 5371: Continuing Appropriations and Extensions Act, 2026
The "Continuing Appropriations and Extensions Act, 2026" aims to ensure ongoing funding and assistance for various federal government programs and departments until the end of fiscal year 2026. This includes critical areas such as health, defense, and public services. The bill sets forth certain conditions and limitations regarding how the appropriated funds can be utilized by these programs and services.
Health Care Provisions
The bill makes amendments to sections of the Public Health Service Act and the Social Security Act. It primarily affects deadlines associated with multiple healthcare initiatives, extending them from September 30, 2025, to November 21, 2025. This includes adjustments related to Medicare and the extension of certain health services.
Reporting Requirements
Beginning in fiscal year 2021, the bill establishes mandatory annual reporting requirements regarding the Food and Drug Administration (FDA). These reports must be submitted within 120 days after the fiscal year ends and will cover updates on over-the-counter (OTC) monograph orders, facility registrations, and FDA safety activities. Starting in fiscal year 2026, the reports will also need to include specific performance metrics and will maintain confidentiality for sensitive information.
Budgetary Implications
It is also noted that divisions B through D of this bill will not be counted in the PAYGO scorecards, meaning they will not impact certain budgetary constraints and calculations under existing budget acts.
Relevant Companies
None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
1 sponsor
Actions
3 actions
| Date | Action |
|---|---|
| Sep. 16, 2025 | Introduced in House |
| Sep. 16, 2025 | Referred to the Committee on Appropriations, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| Sep. 16, 2025 | Rules Committee Resolution H. Res. 722 Reported to House. Rule provides for consideration of H.R. 5371 and H. Res. 719. The resolution provides for consideration of H.R. 5371 and H. Res. 719 under a closed rule with one hour of general debate and one motion to recommit on H.R. 5371. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.